Adding a fatty acid inhibitor to chemotherapy regimens could improve treatment efficacy for some oncology patients, according to a study conducted at Ann Arbor-based Michigan Medicine. 

The FDA has accepted the application for suzetrigine, an experimental, non-opioid pain medicine. If approved, the drug will be the nation's first of a new class of pain medicine in more than 20 years. 

Advocate Health, a system with 68 hospitals across six states, recently surveyed its pharmacists to uncover areas of improvement and differences in opinion, according to the American Society of Health-System Pharmacists. 

The fully remote PharmD program at University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science in Aurora has received full accreditation from the Accreditation Council for Pharmacy Education. 

Hospitals spent about 7% of annual pharmaceutical spend on infectious disease treatments, according to a Vizient report released July 30. 

Health systems spent 77% more on semaglutide, the active ingredient of Ozempic and Wegovy, between April 2023 and March 2024, compared to the prior year, according to Vizient's Pharmacy Market Outlook. 

Patients are becoming less satisfied with physical pharmacies as popularity rises for online and mail-order services, according to J.D. Power's 16th annual U.S. Pharmacy Study.

Between April 2023 and March 2024, Humira accounted for top medication spend for Vizient pharmacy program participants, according to a Vizient report published July 30. 

In the second quarter of 2024, there were 300 medications in shortage across the U.S. 

Loma Linda (Calif.) University Health is collaborating with data analytics firm Loopback Analytics to level up the health system's specialty pharmacy services.

A generic drugmaker likely will shut down if it does not receive federal assistance, The Wall Street Journal reported July 26. 

Epidemiologists and virologists are moving away from the term "booster" to describe COVID-19 vaccines, according to a July 26 ABC News report. 

The FDA is warning healthcare providers of dosing errors associated with compounded versions of semaglutide, the active ingredient in Ozempic, Rybelsus and Wegovy.

Ozempic and other GLP-1 medications are increasingly affecting hospital operations and the U.S. healthcare industry. 

Walmart has opened 25 new autoimmune-focused specialty pharmacies across the U.S.

Walgreens has received $25 million in federal funding to conduct a decentralized clinical trial on COVID-19 vaccine immunity. 

On July 17, Roche published early results from a phase 1 trial of an experimental GLP-1 pill for obesity. That day, the drugmaker gained $16.8 billion in its market value, Bloomberg reported. 

Compared to a year prior, more pharmacists, physicians, physician assistants and nurse practitioners agree that pharmacists should have more primary care duties, according to a survey conducted by Surescripts. 

On July 22, Hikma Pharmaceuticals announced a voluntary recall of one lot of intravenous bags after a reported adverse event.

An investigation by federal lawmakers found that pharmacy-benefit managers promised to control costs but have instead steered patients toward higher-priced medicines and affiliated pharmacies that reduce patient choice, The Wall Street Journal reported July 23.